Skip to main content
Xenon Pharmaceuticals Inc. (XENE)
NASDAQ: XENE · Real-Time Price · USD
40.48
-0.52 (-1.27%)
At close: Nov 13, 2026, 4:00 PM EST
39.69
-0.79 (-1.95%)
After-hours: Nov 13, 2026, 7:51 PM EST

Xenon Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-428.73-345.91-234.33-182.39-125.37-78.88
Depreciation & Amortization
2.322.542.562.061.410.91
Loss (Gain) From Sale of Investments
-0.650.63--3.552.930.72
Stock-Based Compensation
64.2953.7150.7232.3720.3810.02
Other Operating Activities
-6.295.56-6.05-5.50.910.39
Change in Accounts Receivable
-0.360.1-0.610.131.76-0.46
Change in Accounts Payable
7.615.518.533.938.062.97
Change in Unearned Revenue
------3.64
Change in Other Net Operating Assets
5.72-1.26-2.21.84-11.1-1.52
Operating Cash Flow
-356.1-279.12-181.39-151.11-101.03-69.5
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1.01-0.8-3.08-5.62-2.89-2.05
Investment in Securities
-621.62218.8168.08-105.77-290.51-244.72
Investing Cash Flow
-622.63218165-111.39-293.41-246.77

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
956.8117.1112.13353.52278.47447.54
Financing Cash Flow
956.8117.1112.13353.52278.47447.54

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-0.030.46-1.670.38-2.48-0.59
Net Cash Flow
-21.9556.45-5.9391.4-118.45130.68

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-357.11-279.92-184.46-156.73-103.92-71.55
Free Cash Flow Growth
------
Free Cash Flow Margin
--3732.23%---1101.57%-388.09%
Free Cash Flow Per Share
-3.89-3.53-2.37-2.34-1.72-1.64
Levered Free Cash Flow
-209.31-175.08-117.59-99.88-54.3-43.76
Unlevered Free Cash Flow
-209.31-175.08-117.59-99.88-54.3-43.76

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Change in Working Capital
12.974.365.715.9-1.28-2.65
SEC Filings: 10-K · 10-Q